These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11738533)

  • 1. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction.
    Auslander LA; Perry W; Jeste DV
    Schizophr Res; 2002 Jan; 53(3):199-207. PubMed ID: 11738533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ego Impairment Index and schizophrenia: a validation study.
    Perry W; Viglione D; Braff D
    J Pers Assess; 1992 Aug; 59(1):165-75. PubMed ID: 1512674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematized delusions and neuropsychological function in paranoid and nonparanoid schizophrenia.
    Kremen WS; Seidman LJ; Goldstein JM; Faraone SV; Tsuang MT
    Schizophr Res; 1994 Jun; 12(3):223-36. PubMed ID: 8054314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paranoid and nonparanoid schizophrenia: drive dominated thinking and thought pathology at two phases of disorder.
    Lazar BS; Harrow M
    J Clin Psychol; 1985 Mar; 41(2):145-51. PubMed ID: 3980736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.
    Zalewski C; Johnson-Selfridge MT; Ohriner S; Zarrella K; Seltzer JC
    Schizophr Bull; 1998; 24(1):127-45. PubMed ID: 9502551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the Ego Impairment Index across the schizophrenia spectrum.
    Perry W; Minassian A; Cadenhead K; Sprock J; Braff D
    J Pers Assess; 2003 Feb; 80(1):50-7. PubMed ID: 12584067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impairment on measures of attention in patients with paranoid and nonparanoid schizophrenia.
    Chan MW; Yip JT; Lee TM
    J Psychiatr Res; 2004; 38(2):145-52. PubMed ID: 14757328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression.
    Bentall RP; Rowse G; Shryane N; Kinderman P; Howard R; Blackwood N; Moore R; Corcoran R
    Arch Gen Psychiatry; 2009 Mar; 66(3):236-47. PubMed ID: 19255373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinements in the Rorschach Ego Impairment Index incorporating the human representational variable.
    Viglione DJ; Perry W; Meyer G
    J Pers Assess; 2003 Oct; 81(2):149-56. PubMed ID: 12946921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Meta-Analysis of the relationship between the Rorschach Ego Impairment Index (EII) and psychiatric severity.
    Diener MJ; Hilsenroth MJ; Shaffer SA; Sexton JE
    Clin Psychol Psychother; 2011; 18(6):464-85. PubMed ID: 20941796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental validity of the Ego Impairment Index: a re-examination of Dawes (1999).
    Perry W
    Psychol Assess; 2001 Sep; 13(3):403-7. PubMed ID: 11556278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral ventricular enlargement in subtypes of chronic schizophrenia.
    Nasrallah HA; Jacoby CG; McCalley-Whitters M; Kuperman S
    Arch Gen Psychiatry; 1982 Jul; 39(7):774-7. PubMed ID: 6984642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranoid Schizophrenia versus Schizoaffective Disorder: Neuropsychological Aspects.
    Leposavić L; Leposavić I; Šaula-Marojević B; Gavrilović P
    Srp Arh Celok Lek; 2015; 143(7-8):391-6. PubMed ID: 26506747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premorbid social competence and paranoid-nonparanoid status in female schizophrenic patients.
    Zigler E; Levine J; Zigler B
    J Nerv Ment Dis; 1977 May; 164(5):333-9. PubMed ID: 864446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder.
    Candido CL; Romney DM
    J Affect Disord; 2002 Aug; 70(3):261-71. PubMed ID: 12128238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotion recognition in Chinese people with schizophrenia.
    Chan CC; Wong R; Wang K; Lee TM
    Psychiatry Res; 2008 Jan; 157(1-3):67-76. PubMed ID: 17928068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of Rorschach developmental level and form-level systems as indicators of psychosis.
    Harder DW; Ritzler BA
    J Pers Assess; 1979 Aug; 43(4):347-54. PubMed ID: 480107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the mental representations of paranoid schizophrenics be differentiated from those of normals?
    Johnson DR; Quinlan DM
    J Pers Assess; 1993 Jun; 60(3):588-601. PubMed ID: 8336271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rorschach Ego Impairment Index in heterogeneous psychiatric patients.
    Adrian C; Kaser-Boyd N
    J Pers Assess; 1995 Dec; 65(3):408-14. PubMed ID: 8609582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of new and revised Rorschach measures of schizophrenic functioning in a Serbian clinical sample.
    Dzamonja-Ignjatovic T; Smith BL; Djuric Jocic D; Milanovic M
    J Pers Assess; 2013; 95(5):471-8. PubMed ID: 23844937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.